$MYSZ
My Size, Inc.

2012 Q1 Form 10-K Financial Statement

#000117891312000920 Filed on March 30, 2012

View on sec.gov

Income Statement

Concept 2012 Q1 2010 Q4 2010
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $310.0K $130.0K $130.0K
YoY Change 933.33% -7.14% 30.0%
% of Gross Profit
Research & Development 297.0K ILs $0.00 3.642M ILs
YoY Change -25.38% 884.32%
% of Gross Profit
Depreciation & Amortization 13.00K ILs $10.00K 31.00K ILs
YoY Change 62.5%
% of Gross Profit
Operating Expenses 1.475M ILs $130.0K 4.218M ILs
YoY Change 184.2% -103.01% 778.75%
Operating Profit -1.475M ILs -4.218M ILs
YoY Change 184.2%
Interest Expense $10.00K $20.00K $0.00
YoY Change -200.0%
% of Operating Profit
Other Income/Expense, Net 46.00K ILs -485.0K ILs
YoY Change 53.33% -2525.0%
Pretax Income -$380.0K -$110.0K -$1.230M
YoY Change 171.43% -102.56% 167.39%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -1.429M ILs -$110.0K -4.703M ILs
YoY Change 192.23% -102.56% 174.23%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$6.33 -$26.34 -$41.00
COMMON SHARES
Basic Shares Outstanding 23.81M
Diluted Shares Outstanding

Balance Sheet

Concept 2012 Q1 2010 Q4 2010
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.00K $260.0K $260.0K
YoY Change -33.33% 0.0% 0.0%
Cash & Equivalents 90.00K ILs 922.0K ILs $260.0K
Short-Term Investments
Other Short-Term Assets $0.00
YoY Change -100.0%
Inventory
Prepaid Expenses
Receivables $90.00K $40.00K
Other Receivables $0.00 $0.00
Total Short-Term Assets 420.0K ILs 1.055M ILs $300.0K
YoY Change 281.82% 210.29% -11.76%
LONG-TERM ASSETS
Property, Plant & Equipment 217.0K ILs $80.00K $80.00K
YoY Change 210.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets 217.0K ILs 268.0K ILs $80.00K
YoY Change 171.25% 2580.0% 700.0%
TOTAL ASSETS
Total Short-Term Assets 420.0K ILs 1.055M ILs $300.0K
Total Long-Term Assets 217.0K ILs 268.0K ILs $80.00K
Total Assets 637.0K ILs 1.323M ILs $380.0K
YoY Change 235.26% 278.0% 8.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $470.0K $130.0K $130.0K
YoY Change 571.43% -56.67% -56.67%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities 3.061M ILs 459.0K ILs $130.0K
YoY Change 4272.86% -30.45% -80.3%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $70.00K $90.00K $90.00K
YoY Change -22.22%
Total Long-Term Liabilities 185.0K ILs 1.039M ILs $90.00K
YoY Change 105.56%
TOTAL LIABILITIES
Total Short-Term Liabilities 3.061M ILs 459.0K ILs $130.0K
Total Long-Term Liabilities 185.0K ILs 1.039M ILs $90.00K
Total Liabilities 3.246M ILs 1.498M ILs $220.0K
YoY Change 1928.75% 126.97% -66.67%
SHAREHOLDERS EQUITY
Retained Earnings -11.59M ILs -9.117M ILs
YoY Change
Common Stock 93.00K ILs 38.00K ILs
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -2.609M ILs -175.0K ILs $160.0K
YoY Change
Total Liabilities & Shareholders Equity 637.0K ILs 1.323M ILs $380.0K
YoY Change 235.26% 278.0% 8.57%

Cashflow Statement

Concept 2012 Q1 2010 Q4 2010
OPERATING ACTIVITIES
Net Income -1.429M ILs -$110.0K -4.703M ILs
YoY Change 192.23% -102.56% 174.23%
Depreciation, Depletion And Amortization 13.00K ILs $10.00K 31.00K ILs
YoY Change 62.5%
Cash From Operating Activities -938.0K ILs -$340.0K -3.094M ILs
YoY Change 14.81% -189.47% 673.5%
INVESTING ACTIVITIES
Capital Expenditures 5.000K ILs -195.0K ILs
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 -$60.00K -$50.00K
YoY Change -60.0% 66.67%
Cash From Investing Activities -5.000K ILs -$60.00K -195.0K ILs
YoY Change -60.0% 550.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net 104.0K ILs 0.000 ILs
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 104.0K ILs 730.0K 3.465M ILs
YoY Change -417.39%
NET CHANGE
Cash From Operating Activities -938.0K ILs -340.0K -3.094M ILs
Cash From Investing Activities -5.000K ILs -60.00K -195.0K ILs
Cash From Financing Activities 104.0K ILs 730.0K 3.465M ILs
Net Change In Cash -839.0K ILs 330.0K 176.0K ILs
YoY Change 2.69% -140.93%
FREE CASH FLOW
Cash From Operating Activities -938.0K ILs -$340.0K -3.094M ILs
Capital Expenditures 5.000K ILs -195.0K ILs
Free Cash Flow -943.0K ILs -2.899M ILs
YoY Change 15.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2011 dei Amendment Flag
AmendmentFlag
false
CY2011 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2011 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2011 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2011
CY2011 dei Document Period End Date
DocumentPeriodEndDate
2011-12-31
CY2011 dei Document Type
DocumentType
10-K
CY2011 dei Entity Central Index Key
EntityCentralIndexKey
0001211805
CY2012Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23814428
CY2011 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2011 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2011Q2 dei Entity Public Float
EntityPublicFloat
10000000 USD
CY2011 dei Entity Registrant Name
EntityRegistrantName
TOPSPIN MEDICAL INC
CY2011 dei Entity Voluntary Filers
EntityVoluntaryFilers
Yes
CY2011 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2011 topmd Recapitalization Of Equity Upon Reverse Acquisition
RecapitalizationOfEquityUponReverseAcquisition
595000 ILS
CY2010 topmd Recapitalization Of Equity Upon Reverse Acquisition
RecapitalizationOfEquityUponReverseAcquisition
ILS
topmd Recapitalization Of Equity Upon Reverse Acquisition
RecapitalizationOfEquityUponReverseAcquisition
595000 ILS
CY2011 topmd Stock Issued During Period Value Recapitalization Of Equity
StockIssuedDuringPeriodValueRecapitalizationOfEquity
-1186000 ILS
CY2011 topmd Weighted Average Number Of Shares Outstanding Basic And Diluted Duration
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedDuration
9967875
CY2010 topmd Weighted Average Number Of Shares Outstanding Basic And Diluted Duration
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedDuration
8673800
topmd Weighted Average Number Of Shares Outstanding Basic And Diluted Duration
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedDuration
8673800
CY2011Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8527000 ILS
CY2010Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8904000 ILS
CY2008 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
394000 ILS
CY2010 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
409000 ILS
CY2011 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
70000 ILS
CY2010 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
ILS
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
70000 ILS
CY2011Q4 us-gaap Assets
Assets
1565000 ILS
CY2010Q4 us-gaap Assets
Assets
1323000 ILS
CY2011Q4 us-gaap Assets Current
AssetsCurrent
1340000 ILS
CY2010Q4 us-gaap Assets Current
AssetsCurrent
1055000 ILS
CY2011Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
225000 ILS
CY2010Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
268000 ILS
CY2011Q4 us-gaap Business Acquisition Cost Of Acquired Entity Cash Paid
BusinessAcquisitionCostOfAcquiredEntityCashPaid
-595000 ILS
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
929000 ILS
CY2010Q4 us-gaap Business Acquisition Cost Of Acquired Entity Cash Paid
BusinessAcquisitionCostOfAcquiredEntityCashPaid
ILS
CY2011Q4 us-gaap Business Acquisition Cost Of Acquired Entity Equity Interests Issued And Issuable
BusinessAcquisitionCostOfAcquiredEntityEquityInterestsIssuedAndIssuable
1186000 ILS
CY2010Q4 us-gaap Business Acquisition Cost Of Acquired Entity Equity Interests Issued And Issuable
BusinessAcquisitionCostOfAcquiredEntityEquityInterestsIssuedAndIssuable
ILS
CY2011Q4 us-gaap Business Acquisition Cost Of Acquired Entity Purchase Price
BusinessAcquisitionCostOfAcquiredEntityPurchasePrice
1781000 ILS
CY2010Q4 us-gaap Business Acquisition Cost Of Acquired Entity Purchase Price
BusinessAcquisitionCostOfAcquiredEntityPurchasePrice
ILS
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
922000 ILS
CY2009Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
746000 ILS
CY2011Q4 us-gaap Business Acquisition Purchase Price Allocation Current Assets Prepaid Expense And Other Assets
BusinessAcquisitionPurchasePriceAllocationCurrentAssetsPrepaidExpenseAndOtherAssets
-818000 ILS
CY2010Q4 us-gaap Business Acquisition Purchase Price Allocation Current Assets Prepaid Expense And Other Assets
BusinessAcquisitionPurchasePriceAllocationCurrentAssetsPrepaidExpenseAndOtherAssets
ILS
CY2011Q4 us-gaap Business Acquisition Purchase Price Allocation Current Liabilities Other Liabilities
BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesOtherLiabilities
-978000 ILS
CY2010Q4 us-gaap Business Acquisition Purchase Price Allocation Current Liabilities Other Liabilities
BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesOtherLiabilities
ILS
CY2011Q4 us-gaap Business Acquisition Purchase Price Allocation Deferred Income Taxes Asset Liability Net
BusinessAcquisitionPurchasePriceAllocationDeferredIncomeTaxesAssetLiabilityNet
1351000 ILS
CY2010Q4 us-gaap Business Acquisition Purchase Price Allocation Deferred Income Taxes Asset Liability Net
BusinessAcquisitionPurchasePriceAllocationDeferredIncomeTaxesAssetLiabilityNet
ILS
CY2011Q4 us-gaap Business Acquisition Purchase Price Allocation Other Noncurrent Assets
BusinessAcquisitionPurchasePriceAllocationOtherNoncurrentAssets
270000 ILS
CY2010Q4 us-gaap Business Acquisition Purchase Price Allocation Other Noncurrent Assets
BusinessAcquisitionPurchasePriceAllocationOtherNoncurrentAssets
ILS
CY2008Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
ILS
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
7000 ILS
CY2010 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
176000 ILS
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
929000 ILS
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
ILS
CY2010Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
ILS
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22355929
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22355929
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
87000 ILS
CY2010Q4 us-gaap Common Stock Value
CommonStockValue
38000 ILS
CY2011 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
858000 ILS
CY2010 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
ILS
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
858000 ILS
CY2011Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
1351000 ILS
CY2010Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
ILS
CY2011 us-gaap Depreciation
Depreciation
43000 ILS
CY2010 us-gaap Depreciation
Depreciation
31000 ILS
us-gaap Depreciation
Depreciation
92000 ILS
CY2011 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.1
CY2010 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.52
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
1.14
CY2011Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
132000 ILS
CY2010Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
233000 ILS
CY2011 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
546000 ILS
CY2010 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
576000 ILS
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1963000 ILS
CY2011 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-110000 ILS
CY2010 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-109000 ILS
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
209000 ILS
CY2011 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-15000 ILS
CY2010 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
114000 ILS
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
124000 ILS
CY2011 us-gaap Increase Decrease In Postemployment Obligations
IncreaseDecreaseInPostemploymentObligations
-71000 ILS
CY2010 us-gaap Increase Decrease In Postemployment Obligations
IncreaseDecreaseInPostemploymentObligations
22000 ILS
us-gaap Increase Decrease In Postemployment Obligations
IncreaseDecreaseInPostemploymentObligations
2000 ILS
CY2011 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
24000 ILS
CY2010 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-140000 ILS
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
157000 ILS
CY2011Q4 us-gaap Interest Payable Current
InterestPayableCurrent
386000 ILS
CY2010Q4 us-gaap Interest Payable Current
InterestPayableCurrent
226000 ILS
CY2011Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
225000 ILS
CY2010Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
268000 ILS
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1565000 ILS
CY2010Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1323000 ILS
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2933000 ILS
CY2010Q4 us-gaap Liabilities Current
LiabilitiesCurrent
459000 ILS
CY2011Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
177000 ILS
CY2010Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1039000 ILS
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1947000 ILS
CY2010 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3465000 ILS
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9998000 ILS
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
ILS
us-gaap Operating Expenses
OperatingExpenses
9853000 ILS
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
-1280000 ILS
CY2010 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-195000 ILS
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-316000 ILS
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1940000 ILS
CY2010 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3094000 ILS
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8753000 ILS
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-1042000 ILS
CY2010 us-gaap Net Income Loss
NetIncomeLoss
-4703000 ILS
CY2009 us-gaap Net Income Loss
NetIncomeLoss
-1715000 ILS
us-gaap Net Income Loss
NetIncomeLoss
-10159000 ILS
CY2008 us-gaap Net Income Loss
NetIncomeLoss
-1646000 ILS
us-gaap Net Income Loss
NetIncomeLoss
-1053000 ILS
CY2011 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
238000 ILS
CY2010 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-485000 ILS
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-306000 ILS
CY2011 us-gaap Operating Expenses
OperatingExpenses
1280000 ILS
CY2010 us-gaap Operating Expenses
OperatingExpenses
4218000 ILS
CY2010 us-gaap Operating Income Loss
OperatingIncomeLoss
-4218000 ILS
us-gaap Operating Income Loss
OperatingIncomeLoss
-9853000 ILS
CY2011Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
1064000 ILS
CY2010Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
ILS
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
ILS
CY2010 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-195000 ILS
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-316000 ILS
CY2011Q4 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
2000 ILS
CY2010Q4 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
73000 ILS
CY2011Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
411000 ILS
CY2010Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
133000 ILS
CY2011 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
ILS
CY2010 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
ILS
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4586000 ILS
CY2011 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
ILS
CY2010 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
1870000 ILS
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
1870000 ILS
CY2011 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
1352000 ILS
CY2010 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
ILS
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
1352000 ILS
CY2011 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
ILS
CY2010 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1595000 ILS
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1595000 ILS
CY2011 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
734000 ILS
CY2010 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3642000 ILS
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7890000 ILS
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10159000 ILS
CY2010Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9117000 ILS
CY2011 us-gaap Share Based Compensation
ShareBasedCompensation
-481000 ILS
CY2010 us-gaap Share Based Compensation
ShareBasedCompensation
1012000 ILS
us-gaap Share Based Compensation
ShareBasedCompensation
977000 ILS
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
-1545000 ILS
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
-175000 ILS
CY2009Q4 us-gaap Stockholders Equity
StockholdersEquity
566000 ILS
CY2008Q4 us-gaap Stockholders Equity
StockholdersEquity
2281000 ILS
CY2007Q4 us-gaap Stockholders Equity
StockholdersEquity
928000 ILS
CY2007Q1 us-gaap Stockholders Equity
StockholdersEquity
ILS
CY2011 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
858000 ILS
CY2010 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
207000 ILS
CY2008 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2605000 ILS
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1981000 ILS
CY2011 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
ILS
CY2010 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
3346000 ILS
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1743000 ILS
CY2011 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
310000 ILS
CY2010 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-399000 ILS
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-89000 ILS
CY2011Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
175000 ILS
CY2010Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
966000 ILS

Files In Submission

Name View Source Status
0001178913-12-000920-index-headers.html Edgar Link pending
0001178913-12-000920-index.html Edgar Link pending
0001178913-12-000920.txt Edgar Link pending
0001178913-12-000920-xbrl.zip Edgar Link pending
exhibit_10-19.htm Edgar Link pending
exhibit_23-1.htm Edgar Link pending
exhibit_31-1.htm Edgar Link pending
exhibit_31-2.htm Edgar Link pending
exhibit_32-1.htm Edgar Link pending
ey_color.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
topmd-20111231.xml Edgar Link completed
topmd-20111231.xsd Edgar Link pending
topmd-20111231_cal.xml Edgar Link unprocessable
topmd-20111231_def.xml Edgar Link unprocessable
topmd-20111231_lab.xml Edgar Link unprocessable
topmd-20111231_pre.xml Edgar Link unprocessable
zk1211234.htm Edgar Link pending